An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
DocGo Names Aaron Severs as Chief Product Officer to Lead Consumer Product Strategy
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
DocGo has appointed Aaron Severs as Chief Product Officer, aiming to enhance its technology and software offerings. Severs brings extensive experience from Mindbody and has a history of leading SaaS products. The company plans to leverage his expertise to expand its mobile health services into the B2C market, catering to the growing demand for accessible healthcare. With HealthPoint's 800,000 registered users, DocGo seeks to improve health outcomes through technology-driven solutions. The move aligns with industry trends favoring telemedicine and consumer-friendly healthcare delivery.
Positive
Appointment of Aaron Severs as Chief Product Officer to drive technology investment.
Severs' extensive experience in SaaS products is expected to enhance DocGo's offerings.
HealthPoint's large user base (800,000 registered users) provides a strong foundation for growth.
Focus on expanding mobile health services into the B2C space aligns with market demand.
Negative
None.
Severs previously served as Vice President, Product and Technology at Mindbody, an industry-leading software-as-a-service health and wellness company
NEW YORK--(BUSINESS WIRE)--
DocGo, a leading provider of last-mile mobile health services and integrated medical mobility solutions (Nasdaq: DCGO), announced the hire of Aaron Severs as their new Chief Product Officer. Severs is a global product and engineering executive with a proven track record leading software-as-a-service (SaaS) products and technology platform strategies to deliver enterprise-wide growth and recurring revenue.
“DocGo is looking to increase investment in our technology, software, and product offerings, and Aaron will be a key player in these initiatives,” said President of DocGo, Anthony Capone. “HealthPoint has close to 800,000 registered users. Aaron will be helping us greatly increase the value we provide to businesses and consumers and help drive our expansion of comprehensive mobile health services into the B2C space.”
HealthPoint, DocGo’s patient EMR, gives users complete access to their health records and provides a secure and intuitive self-service platform for ordering on-site medical care. Severs’ extensive background includes two successful startup exits and executive roles leading high-growth product lines at both private and public technology companies.
“Dramatic increases in telemedicine adoption during the pandemic demonstrated that the healthcare industry is primed for lasting, tech-enabled change,” said Severs. “Underserved patient populations need more accessible care and macro trends see consumers demanding more and more services on their own terms. DocGo is leading the industry to a more consumer-friendly and efficient healthcare delivery model that can achieve improved patient outcomes and ultimately better lives. That's why I'm joining, and I couldn't be more thrilled to be part of this great team.”
About DocGo DocGo is a leading provider of last-mile mobile care services and integrated medical mobility solutions. DocGo is disrupting the traditional four-wall healthcare system by providing care at the scale of humanity. DocGo's innovative technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks, and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace. Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit www.docgo.com.
This announcement contains forward-looking statements (including within the meaning of Section 21E of the U.S. Securities Exchange Act of 1934, as amended, and Section 27A of the U.S. Securities Act of 1933, as amended) concerning DocGo. These statements include, but are not limited to, statements that address our expected future business and financial performance and statements about (i) our plans, objectives and intentions with respect to future operations, services and products, (ii) our competitive position and opportunities, and (iii) other statements identified by words such as "may", "will", "expect", "intend", "plan", "potential", "believe", "seek", "could", "estimate", "judgment", "targeting", "should", "anticipate", "predict" "project", "aim", "goal", “outlook”, “guidance”, and similar words, phrases or expressions. These forward-looking statements are based on management's current expectations and beliefs, as well as assumptions made by, and information currently available to, management, and current market trends and conditions. Forward-looking statements inherently involve risks and uncertainties, many of which are beyond our control, and which may cause actual results to differ materially from those contained in our forward-looking statements. Accordingly, you should not place undue reliance on such statements. Particular uncertainties that could materially affect current or future results include possible accounting adjustments made in the process of finalizing reported financial results; any risks associated with global economic conditions and concerns; the effects of global outbreaks of pandemics or contagious diseases or fear of such outbreaks, such as the COVID-19 coronavirus pandemic; competitive pressures; pricing declines; rates of growth in our target markets; our ability to improve gross margins; cost-containment measures; legislative and regulatory actions; the impact of legal proceedings and compliance risks; the impact on our business and reputation in the event of information technology system failures, network disruptions, cyber-attacks, or losses or unauthorized access to, or release of, confidential information; and the ability of the company to comply with laws and regulations regarding data privacy and protection. We undertake no intent or obligation to publicly update or revise any of these forward-looking statements, whether as a result of new information, future events or otherwise.
